Table of Contents
Journal of Biophysics
Volume 2017 (2017), Article ID 3057329, 7 pages
https://doi.org/10.1155/2017/3057329
Research Article

Effect of Ultraviolet Light Irradiation Combined with Riboflavin on Different Bacterial Pathogens from Ocular Surface Infection

1Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University and Beijing Ophthalmology & Visual Sciences Key Laboratory, National Engineering Research Center for Ophthalmology, Beijing 100005, China
2INSERM, U968 and UMR_S 968, Institut de la Vision, University Paris 06 (UPMC) and CNRS, UMR_7210, 75012 Paris, France
3Quinze-Vingts National Ophthalmology Hospital, Paris and Versailles Saint-Quentin-en-Yvelines University, Versailles, France

Correspondence should be addressed to Qingfeng Liang

Received 22 May 2017; Revised 2 August 2017; Accepted 29 August 2017; Published 12 October 2017

Academic Editor: Andrei B. Rubin

Copyright © 2017 Jing Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Whitcher and M. Srinvasan, “Corneal ulceration in developing world: a silent epidemic,” British Journal of Ophthalmology, vol. 81, pp. 622-623, 1997. View at Google Scholar
  2. X. Song, L. Xie, X. Tan et al., “A multi-center, cross-sectional study on the burden of infectious keratitis in China,” PLoS ONE, vol. 9, no. 12, p. e113843, 2014. View at Publisher · View at Google Scholar
  3. S. C. Xu, J. Chow, and J. Liu, “Risk factors for visual impairment associated with corneal diseases in southern China,” Clinical Ophthalmology, pp. 777–782, 2016. View at Publisher · View at Google Scholar
  4. M. Green, A. Apel, and F. Stapleton, “Risk factors and causative organisms in microbial keratitis,” Cornea, vol. 27, no. 1, pp. 22–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. C. Neu, “The crisis in antibiotic resistance,” Science, vol. 257, no. 5073, pp. 1064–1073, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. B. J. Dahl, E. Spotts, and J. Q. Truong, “Corneal collagen cross-linking: an introduction and literature review,” Optometry, vol. 83, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. O'Brart, T. Q. Kwong, P. Patel, R. J. McDonald, and N. A. O'Brart, “Long-term follow-up of riboflavin/ultraviolet A (370nm) corneal collagen cross-linking to halt the progression of keratoconus,” British Journal of Ophthalmology, vol. 97, no. 4, pp. 433–437, 2013. View at Publisher · View at Google Scholar
  8. H. P. T. M. Iseli, F. Hafezi, J. Kampmeier, and T. Seiler, “Ultraviolet a/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts,” Cornea, vol. 27, no. 5, pp. 590–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. J. Makdoumi and S. Crafoord, “Infectious keratitis treated with corneal crosslinking,” Cornea, vol. 29, no. 12, pp. 1353–1358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Moren, J. Mortensen, and A. Ohrstrom, “Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis,” Cornea, vol. 29, no. 1, pp. 102–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Wainwright, “Photodynamic antimicrobial chemotherapy (PACT),” Journal of Antimicrobial Chemotherapy, vol. 42, no. 1, pp. 13–28, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Jori, C. Fabris, M. Soncin et al., “Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications,” Lasers in Surgery and Medicine, vol. 38, no. 5, pp. 468–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. F. Donnelly, P. A. McCarron, and M. M. Tunney, “Antifungal photodynamic therapy,” Microbiological Research, vol. 163, no. 1, pp. 1–12, 2008. View at Publisher · View at Google Scholar
  14. T. Maisch, “A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 8, pp. 974–983, 2009. View at Publisher · View at Google Scholar
  15. F. Giuliani, M. Martinelli, A. Cocchi, D. Arbia, L. Fantetti, and G. Roncucci, “In Vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 2, pp. 637–642, 2010. View at Publisher · View at Google Scholar
  16. B. D. Jett, K. L. Hatter, and M. M. Huycke, “Simplified agar plate method for quantifying viable bacteria,” Biotechniques, vol. 23, pp. 648–650, 1997. View at Google Scholar
  17. J. Moan and Q. Peng, “An outline of the hundred-year history of PDT,” Anticancer Research, vol. 23, pp. 3591–3600, 2003. View at Google Scholar
  18. T. Maisch, R. M. Szeimies, G. Jori, and C. Abels, “Antibacterial photodynamic therapy in dermatology,” Photochemical & Photobiological Sciences, vol. 3, no. 10, pp. 907–917, 2004. View at Publisher · View at Google Scholar
  19. D. E. Dolmans, D. Fukumura, and R. K. Jain, “Photodynamic therapy for cancer,” Nature Reviews Cancer, vol. 3, pp. 380–387, 2003. View at Google Scholar
  20. T. Maisch, “Revitalized strategies against multi-resistant bacteria: antimicrobial photodynamic therapy and bacteriophage therapy,” Anti-Infective Agents in Medicinal Chemistry, vol. 6, no. 2, pp. 145–150, 2007. View at Publisher · View at Google Scholar
  21. M. Wainwright, “The emerging chemistry of blood product disinfection,” Chemical Society Reviews, vol. 31, no. 2, pp. 128–136. View at Publisher · View at Google Scholar
  22. F. Corbin, “Pathogen inactivation of blood components: Current status and introduction of an approach using riboflavin as a photosensitizer,” International Journal of Hematology, vol. 76, no. S2, pp. 253–257, 2002. View at Publisher · View at Google Scholar
  23. K. Sato, H. Taguchi, and T. Maeda, “The primary cytoxicity in ultraviolet-a-irradiated riboflavin solution is derived from hydrogen peroxide,” Journal of Investigative Dermatology, vol. 105, pp. 608–612, 1995. View at Google Scholar
  24. G. Bertoloni, F. M. Lauro, G. Cortella, and M. Merchat, “Photosensitizing activity of hematoporphyrin on Staphylococcus aureus cells,” Biochimica et Biophysica Acta—General Subjects, vol. 1475, no. 2, pp. 169–174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. and H. F., “Light activated compounds as antimicrobial agents - patently obvious?” Recent Patents on Anti-Infective Drug Discovery, vol. 1, no. 2, pp. 181–199, 2006. View at Publisher · View at Google Scholar
  26. B. C. Wilson and M. S. Patterson, “The physics, biophysics and technology of photodynamic therapy,” Physics in Medicine and Biology, vol. 53, no. 9, pp. R61–R109, 2008. View at Publisher · View at Google Scholar
  27. X. J. Fu, Y. Q. Zhu, Y. B. Peng et al., “Enzyme activated photodynamic therapy for methicillin-resistant Staphylococcus aureus infection both inv itro and in vivo,” Journal of Photochemistry and Photobiology B: Biology, vol. 136, pp. 72–80, 2014. View at Publisher · View at Google Scholar
  28. V. Kumar, O. Lockerbie, S. D. Keil et al., “Riboflavin and UV-Light based pathogen reduction: extent and consequence of DNA damage at the molecular level,” Photochemistry and Photobiology, vol. 80, no. 1, pp. 15–21, 2004. View at Publisher · View at Google Scholar
  29. M. R. Hamblin and T. Hasan, “Photodynamic therapy: a new antimicrobial approach to infectious disease?” Photochemical and Photobiological Sciences, vol. 3, no. 5, pp. 436–450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. H. Abidi, S. K. Sherwani, T. R. Siddiqui, A. Bashir, and S. U. Kazmi, “Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan,” BMC Ophthalmology, vol. 13, no. 1, 2013. View at Publisher · View at Google Scholar
  31. L. Wiley, D. R. Bridge, L. A. Wiley, J. V. Odom, T. Elliott, and J. C. Olson, “Bacterial biofilm diversity in contact lens-related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia,” Investigative Opthalmology & Visual Science, vol. 53, no. 7, pp. 3896–3905, 2012. View at Publisher · View at Google Scholar